What companies are GYRE's competitors?

Gyre Therapeutics, Inc. (GYRE)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does GYRE compare to its peers?

The peer comparison table on this page shows Gyre Therapeutics, Inc. (GYRE) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does GYRE operate in?

Gyre Therapeutics, Inc. (GYRE) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

GYRE

Gyre Therapeutics, Inc.

NASDAQ·Biotechnology · Healthcare

$6.65$0.03−0.45%

After hours·$6.65+0.00%

Market cap$741.40M·Market closed·Aug 26 8:00 PM UTC

Frequently Asked Questions About GYRE

What companies are GYRE's competitors?: Gyre Therapeutics, Inc. (GYRE)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does GYRE compare to its peers?: The peer comparison table on this page shows Gyre Therapeutics, Inc. (GYRE) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does GYRE operate in?: Gyre Therapeutics, Inc. (GYRE) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

GYRE

Gyre Therapeutics, Inc.

NASDAQ·Biotechnology · Healthcare

$6.65$0.03−0.45%

After hours·$6.65+0.00%

Market cap$741.40M·Market closed·Aug 26 8:00 PM UTC

Peers


ERAS	Erasca, Inc.	$19.15	$6.6B
IOVA	Iovance Biotherapeutics, Inc.	$8.08	$3.6B
MBX	MBX Biosciences, Inc. Common Stock	$66.76	$3.2B
AVBP	ArriVent BioPharma, Inc.	$31.14	$1.5B
MGTX	MeiraGTx Holdings plc	$14.56	$1.3B
MLTX	MoonLake Immunotherapeutics	$15.62	$1.3B
CTMX	CytomX Therapeutics, Inc.	$3.32	$722.8M
ATXS	Astria Therapeutics, Inc.	$12.58	$718.1M
KROS	Keros Therapeutics, Inc.	$11.12	$355.8M
AVXL	Anavex Life Sciences Corp.	$3.24	$300.3M

Frequently Asked Questions About GYRE

What companies are GYRE's competitors?: Gyre Therapeutics, Inc. (GYRE)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does GYRE compare to its peers?: The peer comparison table on this page shows Gyre Therapeutics, Inc. (GYRE) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does GYRE operate in?: Gyre Therapeutics, Inc. (GYRE) operates in the Biotechnology industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.